X-trodes is a technology company.
X-trodes has raised $5.0M across 1 funding round.
X-trodes has raised $5.0M in total across 1 funding round.
X-trodes is an Israel-based medtech startup developing Smart Skin, a wireless, wearable patch system for real-time electrophysiological monitoring outside clinical labs.[1][2][4] The technology captures high-quality data on brain (EEG), muscle (EMG), cardiac (ECG), and eye movement (EOG) signals using dry, multi-modal electrode arrays that conform to the skin without gels or wires, enabling everyday use in healthcare, research, sleep monitoring, and athlete muscle recovery.[1][2][4] It serves patients, clinicians, researchers, and athletes by solving the constraints of traditional wired, lab-bound electrophysiology tools, providing medical-grade signal quality in natural environments; the company raised $4.5M in seed funding in 2021 and secured FDA 510(k) clearance in February 2024 for its X-trodes System M.[2][4]
X-trodes emerged from over a decade of research at Prof. Yael Hanein's Neuro Engineering laboratory, where scientists developed the core intellectual property for Smart Skin—a flexible, ultra-thin patch for untethered electrophysiological data collection.[1][3] Founded by researchers and engineers envisioning monitoring beyond equipped medical facilities, the company translated lab innovations into real-world products, including a medical-grade sleep system and athlete muscle recovery wearable.[2][3] Key milestones include a $4.5M seed round in October 2021, partnerships like with Emotiv, awards such as the EIC Grant and EY pitch win, and FDA clearance in February 2024 after validation studies confirming equivalence to clinical devices.[2][3][4] The team blends expertise in research, engineering, and business, supported by an advisory board of medical leaders like Judith A. Owens, MD (sleep medicine) and Alon Avidan, MD (neurology).[3]
X-trodes rides the wave of remote patient monitoring (RPM) and wearable medtech, accelerated by post-pandemic demand for decentralized healthcare and real-world evidence collection.[4] Its timing aligns with surging interest in non-invasive neurotech for sleep disorders, neurology, cardiology, and sports medicine, where traditional electrophysiology is limited by immobility and setup complexity.[1][2] Market forces like aging populations, rising chronic conditions (e.g., sleep apnea affecting millions), and FDA's push for digital health tools favor its wireless, compliant tech, positioning it to influence ecosystems by enabling longitudinal data for AI-driven diagnostics and personalized treatments.[4] As part of the medtech startup boom—alongside peers like Lark and Oshi Health—X-trodes expands accessible electrophysiology, potentially reshaping research and home-based care.[2]
X-trodes is poised for clinical expansion post-FDA clearance, targeting validations for sleep, neurology, and cardiology use cases while scaling production and partnerships.[4] Trends like AI integration for signal analysis, broader RPM adoption, and athlete performance tech will propel growth, with potential for acquisitions by medtech giants amid a market valuing wireless diagnostics.[2][5] Its influence may evolve from research tool to standard in ambulatory monitoring, unlocking "untapped" real-life data to transform healthcare efficiency—echoing its mission to unleash electrophysiology's full potential beyond lab walls.[1]
X-trodes has raised $5.0M in total across 1 funding round.
X-trodes's investors include Welltech Ventures.
X-trodes has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Seed in October 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2021 | $5.0M Seed | Welltech Ventures |